References
- Bibby M.C., Double J.A., Phillips R.M., Loadman P.M. Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). British Journal of Cancer 1987; 55: 159–163
- Bibby M.C., Double J.A., Loadman P.M., Duke C.V. Reduction of tumour blood flow by flavone acetic acid: a possible component of therapy. Journal of the National Cancer Institute 1989a; 8: 216–220
- Bibby M.C., Phillips R.M., Double J.A. Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512). Cancer Chemotherapy and Pharmacology 1989b; 24: 87–94
- Chaplin D.J., Horsman M.R., Peters C.E., Trotter M.J. Tumour blood flow and its modulation: implications for bioreductive drug activity in vivo. NATO Advanced Research Seminar Series, ‘Selective Activation by Redox Processes’. Plenum, New York 1990, (In press).
- Ching L.-M., Baguley B.C. Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512). European Journal of Cancer and Clinical Oncology 1988; 24: 1521–1525
- Corbett T.H., Bissery M.-C., Wozniak A., Plowman J., Polin L., Tapazoglou E., Dieckman J., Valeriote F. Activity of flavone acetic acid (NSC-347512) against solid tumours of mice. Investigational New Drugs 1986; 4: 207–220
- Cummings J., Smyth J.F. Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours. Cancer Chemotherapy and Pharmacology 1989; 24: 269–272
- Evelhoch J.L., Bissery M.-C., Chabot G.G., Simpson N.E., McCoy C.L., Heilbrun L.K., Corbett T.H. Flavone acetic acid (NSC 347512)-induced modulation of murine tumour physiology monitored by in vivo nuclear magnetic resonance spectroscopy. Cancer Research 1988; 48: 4749–4755
- Finlay G.J., Smith G.P., Fray L.M., Baguley B.C. Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect. Journal of the National Cancer Institute 1988; 80: 241–245
- Kerr D.J., Maughan T., Newlands E., Rustin G., Bleehen N.M., Lewis C., Kaye S.B. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. British Journal of Cancer 1989; 60: 104–106
- Murray J.C., Smith K.A., Thurston G. Flavone acetic acid induces a coagulopathy in mice. British Journal of Cancer 1989; 60: 729–733
- Olive P.L. Distribution, oxygenation, and clonogenicity of macrophages in a murine tumour. Cancer Communication 1989; 1: 93–100
- Olive P.L., Durand R.E. Characterization of a carbocyanine derivative as a fluorescent penetration probe. Cytometry 1987; 8: 571–575
- Plowman J., Narayanan V.L., Dykes D., Szarvasi E., Briet P., Yoder O.C., Paull K.D. Flavone acetic acid: a novel agent with preclinical antitumour activity against colon adenocarcinoma 38 in mice. Cancer Treatment Reports 1986; 70: 631–635
- Reinhold H.S., Visser J.W.M. In vivo fluorescence of endothelial cell nuclei stained with the dye bis-benzamide H33342. International Journal of Microcirculation: Clinical and Experimental 1983; 2: 143–146
- Smith G.P., Calveley S.B., Smith M.J., Baguley B.C. Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours. European Journal of Cancer and Clinical Oncology 1987; 23: 1209–1211
- Smith K.A., Hill S.A., Begg A.C., Denekamp J. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours. British Journal of Cancer 1988; 57: 247–253
- Trotter M.J., Chaplin D.J., Durand R.E., Olive P.L. The use of fluorescent probes to identify regions of transient perfusion in murine tumours. International Journal of Radiation Oncology, Biology and Physics 1989a; 16: 931–934
- Trotter M.J., Chaplin D.J., Olive P.L. Use of a carbocyanine dye as a marker of functional vasculature in murine tumours. British Journal of Cancer 1989b; 59: 706–709
- Trotter, M.J., Olive, P.L., Chaplin, D.J. Effect of the vascular marker Hoechst 33342 on tumour perfusion and cardiovascular function in the mouse. British Journal of Cancer, In press, 1990
- Watanabe N., Niitsu Y., Umeno H., Kuriyama H., Neda H., Yamauchi N., Maeda M., Urushizaki I. Toxic effect of tumour necrosis factor on tumour vasculature in mice. Cancer Research 1988; 48: 2179–2183
- Zwi L.J., Baguley B.C., Gavin J.B., Wilson W.R. Blood flow failure as a major determinant in the antitumour action of flavone acetic acid. Journal of the National Cancer Institute 1989; 81: 1005–1013
- Zwi L.G., Baguley B.C., Gavin J.B., Wilson W.R. The use of vascularised spheroids to investigate the action of flavone acetic acid on tumour blood vessels. British Journal of Cancer 1990; 62: 231–237